VETOPHAGE has a technological platform based on the use of phage proteins, natural and effective solutions that are reinventing the management of bacterial infections. Through our endolysins and capture proteins, we are paving the way for a new era of diagnostic and therapeutic solutions for health.

Our technology is the result of advanced research and a clear vision: to offer alternatives to antibiotics for more sustainable and resilient health. To date, we are independently leading two flagship projects:

• A diagnostic project focused on the early detection of bovine mastitis using highly specific phage proteins, enabling proactive and targeted management of these costly infections for the dairy industry.
• An innovative therapeutic project for the treatment of canine pyoderma, using endolysins to combat pathogenic bacteria while preserving the animal’s natural microbiome.

To move forward, we deeply believe in the power of partnerships and collaborations. We are open to any opportunities for co-development, strategic partnerships, or service provision aimed at harnessing the full potential of phages for better management of infectious diseases. Together, we can face the challenges of tomorrow and develop truly innovative solutions to improve health.